Literature DB >> 11854211

Cloned Shiga toxin 2 B subunit induces apoptosis in Ramos Burkitt's lymphoma B cells.

Paola Marcato1, George Mulvey, Glen D Armstrong.   

Abstract

The Shiga toxins (Stx1 and Stx2), produced by Shigella dysenteriae type 1 and enterohemorrhagic Escherichia coli, consist of one A subunit and five B subunits. The Stx1 and Stx2 B subunits form a pentameric structure that binds to globotriaosylceramide (Gb3-Cer) receptors on eukaryotic cells and promotes endocytosis. The A subunit then inhibits protein biosynthesis, which triggers apoptosis in the affected cell. In addition to its Gb3-Cer binding activity, the data in the following report demonstrate that the Stx2 B pentamer induces apoptosis in Ramos Burkitt's lymphoma B cells independently of A subunit activity. Apoptosis was not observed in A subunit-free preparations of the Stx1 B pentamer which competitively inhibited Stx2 B pentamer-mediated apoptosis. The pancaspase inhibitor, Z-VAD-fmk, prevented apoptosis in Ramos cells exposed to the Stx2 B subunit, Stx1 or Stx2. Brefeldin A, an inhibitor of the Golgi transport system, also prevented Stx2 B subunit-mediated apoptosis. These observations suggest that the Stx2 B subunit must be internalized, via Gb3-Cer receptors, to induce Ramos cell apoptosis. Moreover, unlike the two holotoxins, Stx2 B subunit-mediated apoptosis does not involve inhibition of protein biosynthesis. This study provides further insight into the pathogenic potential of this family of potent bacterial exotoxins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854211      PMCID: PMC127801          DOI: 10.1128/IAI.70.3.1279-1286.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  47 in total

1.  Regulated expression of the Shiga toxin B gene induces apoptosis in mammalian fibroblastic cells.

Authors:  I Nakagawa; M Nakata; S Kawabata; S Hamada
Journal:  Mol Microbiol       Date:  1999-09       Impact factor: 3.501

2.  A system for production and rapid purification of large amounts of the Shiga toxin/Shiga-like toxin I B subunit.

Authors:  S B Calderwood; D W Acheson; M B Goldberg; S A Boyko; A Donohue-Rolfe
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

3.  Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.

Authors:  C D Gregory; M Rowe; A B Rickinson
Journal:  J Gen Virol       Date:  1990-07       Impact factor: 3.891

4.  Isolation and characterization of functional Shiga toxin subunits and renatured holotoxin.

Authors:  A Donohue-Rolfe; M Jacewicz; G T Keusch
Journal:  Mol Microbiol       Date:  1989-09       Impact factor: 3.501

5.  Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins.

Authors:  Y Endo; K Tsurugi; T Yutsudo; Y Takeda; T Ogasawara; K Igarashi
Journal:  Eur J Biochem       Date:  1988-01-15

6.  The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis.

Authors:  T G Obrig; T P Moran; J E Brown
Journal:  Biochem J       Date:  1987-06-01       Impact factor: 3.857

7.  Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.

Authors:  T Waddell; S Head; M Petric; A Cohen; C Lingwood
Journal:  Biochem Biophys Res Commun       Date:  1988-04-29       Impact factor: 3.575

8.  Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1.

Authors:  A A Lindberg; J E Brown; N Strömberg; M Westling-Ryd; J E Schultz; K A Karlsson
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

9.  Epstein-Barr virus markers in a series of Burkitt's lymphomas from the West Nile District, Uganda.

Authors:  A Geser; G M Lenoir; M Anvret; G Bornkamm; G Klein; E H Williams; D H Wright; G De-The
Journal:  Eur J Cancer Clin Oncol       Date:  1983-10

Review 10.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

View more
  12 in total

1.  Serum amyloid P component binding to Shiga toxin 2 requires both a subunit and B pentamer.

Authors:  Paola Marcato; Kathleen Vander Helm; George L Mulvey; Glen D Armstrong
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

2.  Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways.

Authors:  Fang Liu; Jing Huang; J Evan Sadler
Journal:  Blood       Date:  2011-08-03       Impact factor: 22.113

3.  Retracted science and the retraction index.

Authors:  Ferric C Fang; Arturo Casadevall
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

4.  Activation of the Classical Mitogen-Activated Protein Kinases Is Part of the Shiga Toxin-Induced Ribotoxic Stress Response and May Contribute to Shiga Toxin-Induced Inflammation.

Authors:  Dakshina M Jandhyala; Amrita Ahluwalia; Jennifer J Schimmel; Arlin B Rogers; John M Leong; Cheleste M Thorpe
Journal:  Infect Immun       Date:  2015-10-19       Impact factor: 3.441

5.  Recombinant Shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia.

Authors:  Paola Marcato; Thomas P Griener; George L Mulvey; Glen D Armstrong
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  Oral administration of Shiga toxin-producing Escherichia coli induces intestinal and systemic specific immune response in mice.

Authors:  Romina Jimena Fernandez-Brando; Gabriel Cabrera; Ariela Baschkier; María Pilar Mejías; Cecilia Analia Panek; Elizabeth Miliwebsky; María Jimena Abrey-Recalde; Leticia Verónica Bentancor; María Victoria Ramos; Marta Rivas; Marina Sandra Palermo
Journal:  Med Microbiol Immunol       Date:  2014-01-08       Impact factor: 3.402

7.  Verotoxin activates mitogen-activated protein kinase in human peripheral blood monocytes: role in apoptosis and proinflammatory cytokine release.

Authors:  Pamela Cameron; Susan J Smith; Mark A Giembycz; Dino Rotondo; Robin Plevin
Journal:  Br J Pharmacol       Date:  2003-11-03       Impact factor: 8.739

8.  Shiga toxin as a bacterial defense against a eukaryotic predator, Tetrahymena thermophila.

Authors:  William Lainhart; Gino Stolfa; Gerald B Koudelka
Journal:  J Bacteriol       Date:  2009-06-05       Impact factor: 3.490

9.  Production of secretory immunoglobulin A against Shiga toxin-binding subunits in mice by mucosal immunization.

Authors:  Yasuyuki Imai; Rio Nagai; Yousuke Ono; Tomoyuki Ishikawa; Hiroki Nakagami; Takashi Tanikawa; Kohta Kurohane
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

10.  Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development.

Authors:  Ariane Desselle; Tanguy Chaumette; Marie-Hélène Gaugler; Denis Cochonneau; Julien Fleurence; Nolwenn Dubois; Philippe Hulin; Jacques Aubry; Stéphane Birklé; François Paris
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.